Shanghai Fosun Pharmaceutical Group Co Ltd Financial Flexibility Index
Shanghai Fosun Pharmaceutical Group Co Ltd financial flexibility index. Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of CN¥3.68 Billion (operating CF CN¥2.40 Billion minus capex CN¥1.28 Billion) represents 0% of total liabilities (CN¥57.97 Billion). Explore Shanghai Fosun Pharmaceutical Group Co L capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Financial flexibility index of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Check 600196 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Fosun Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (1998–2025)
Shanghai Fosun Pharmaceutical Group Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Shanghai Fosun Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600196 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥10.45 Billion | CN¥6.01 Billion | CN¥57.97 Billion | ▲ +16.7% |
| 2024 | 0.15x | CN¥8.89 Billion | CN¥4.48 Billion | CN¥57.53 Billion | ▼ -9.5% |
| 2023 | 0.17x | CN¥9.70 Billion | CN¥4.36 Billion | CN¥56.85 Billion | ▼ -10.4% |
| 2022 | 0.19x | CN¥10.11 Billion | CN¥4.22 Billion | CN¥53.05 Billion | ▼ -4.1% |
| 2021 | 0.20x | CN¥8.92 Billion | CN¥3.95 Billion | CN¥44.92 Billion | ▲ +6.7% |
| 2020 | 0.19x | CN¥7.02 Billion | CN¥2.58 Billion | CN¥37.70 Billion | ▼ -4.4% |
| 2019 | 0.19x | CN¥7.18 Billion | CN¥3.22 Billion | CN¥36.92 Billion | ▲ +17.4% |
| 2018 | 0.17x | CN¥6.13 Billion | CN¥2.95 Billion | CN¥36.96 Billion | ▲ +12.4% |
| 2017 | 0.15x | CN¥4.75 Billion | CN¥2.58 Billion | CN¥32.23 Billion | ▼ -32.3% |
| 2016 | 0.22x | CN¥4.03 Billion | CN¥2.11 Billion | CN¥18.52 Billion | ▲ +33.6% |
| 2015 | 0.16x | CN¥2.86 Billion | CN¥1.62 Billion | CN¥17.53 Billion | ▲ +14.0% |
| 2014 | 0.14x | CN¥2.32 Billion | CN¥1.20 Billion | CN¥16.23 Billion | ▼ -17.7% |
| 2013 | 0.17x | CN¥2.05 Billion | CN¥1.01 Billion | CN¥11.81 Billion | ▼ -2.9% |
| 2012 | 0.18x | CN¥1.83 Billion | CN¥665.52 Million | CN¥10.20 Billion | ▲ +75.5% |
| 2011 | 0.10x | CN¥1.11 Billion | CN¥316.65 Million | CN¥10.92 Billion | ▲ +39.6% |
| 2010 | 0.07x | CN¥542.53 Million | CN¥203.36 Million | CN¥7.43 Billion | ▼ -45.2% |
| 2009 | 0.13x | CN¥609.93 Million | CN¥261.87 Million | CN¥4.58 Billion | ▼ -7.1% |
| 2008 | 0.14x | CN¥443.67 Million | CN¥233.04 Million | CN¥3.09 Billion | ▲ +31.1% |
| 2007 | 0.11x | CN¥341.18 Million | CN¥131.48 Million | CN¥3.12 Billion | ▼ -27.7% |
| 2006 | 0.15x | CN¥451.52 Million | CN¥184.91 Million | CN¥2.99 Billion | ▲ +2.8% |
| 2005 | 0.15x | CN¥410.95 Million | CN¥188.35 Million | CN¥2.79 Billion | ▼ -15.5% |
| 2004 | 0.17x | CN¥410.12 Million | CN¥205.10 Million | CN¥2.36 Billion | ▼ -7.5% |
| 2003 | 0.19x | CN¥414.19 Million | CN¥150.14 Million | CN¥2.20 Billion | ▲ +14.0% |
| 2002 | 0.17x | CN¥242.00 Million | CN¥102.47 Million | CN¥1.47 Billion | ▼ -30.4% |
| 2001 | 0.24x | CN¥209.66 Million | CN¥68.15 Million | CN¥884.68 Million | ▼ -68.5% |
| 2000 | 0.75x | CN¥265.05 Million | CN¥138.43 Million | CN¥352.61 Million | ▲ +30.1% |
| 1999 | 0.58x | CN¥116.19 Million | CN¥38.20 Million | CN¥201.15 Million | ▼ -43.4% |
| 1998 | 1.02x | CN¥118.80 Million | CN¥66.55 Million | CN¥116.36 Million | — |